LEADER 00964nam0-2200313---450- 001 990009823610403321 005 20140217113413.0 010 $a88-14-18536-0 035 $a000982361 035 $aFED01000982361 035 $a(Aleph)000982361FED01 035 $a000982361 100 $a20140217d2013----km-y0itay50------ba 101 0 $aita 102 $aIT 105 $ay-------001yy 200 1 $aDella vendita, disposizioni generali, delle obbligazioni del venditore$e[Artt. 1471-1482]$fEnnio Russo 210 $aMilano$cGiuffrè$d©2013 215 $aXVII, 260 p.$d24 cm 225 1 $a<>Codice civile. Commentario 676 $a346.450436302638$v21$zita 700 1$aRusso,$bEnnio$0229060 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990009823610403321 952 $aVIII B 642 (126)$b55344*$fFGBC 959 $aFGBC 996 $aDella vendita, disposizioni generali, delle obbligazioni del venditore$969868 997 $aUNINA LEADER 02994nam 22005534a 450 001 9910144113903321 005 20230721033054.0 010 $a1-281-93903-X 010 $a9786611939038 010 $a0-470-42246-7 010 $a0-470-42245-9 035 $a(CKB)1000000000549814 035 $a(EBL)380571 035 $a(OCoLC)437241507 035 $a(SSID)ssj0000131475 035 $a(PQKBManifestationID)11134966 035 $a(PQKBTitleCode)TC0000131475 035 $a(PQKBWorkID)10026072 035 $a(PQKB)11497513 035 $a(MiAaPQ)EBC380571 035 $a(Au-PeEL)EBL380571 035 $a(CaPaEBR)ebr10263634 035 $a(CaONFJC)MIL193903 035 $a(EXLCZ)991000000000549814 100 $a20081021d2009 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aCoupled bioluminescent assays$b[electronic resource] $emethods, evaluations, and applications /$fMichael J. Corey 210 $aHoboken, N.J. $cWiley$dc2009 215 $a1 online resource (326 p.) 300 $aDescription based upon print version of record. 311 $a0-470-10883-5 320 $aIncludes bibliographical references (p. 265-289) and index. 327 $aIntroduction -- Coupled bioluminescent reactions in practice -- Coupled bioluminescent cytotoxicity assays -- The role of coupled bioluminescent assays in kinase screening and study -- Coupled bioluminescent phosphatase assays -- Acetylcholinesterase -- Measurement of nitric oxide synthase activity by coupled bioluminescence -- The coupled bioluminescent pyrophosphorolysis assay -- Coupled luminescent assays of G-protein-coupled receptors -- Coupled bioluminescent protease assays -- Coupled luminescent assays involving aequorin -- Coupled bioluminescent reporter assays -- Coupled bioluminescent assays : regulatory concerns -- Coupled bioluminescent determination of bioburden and sterility -- Environmental applications of coupled bioluminescent assays. 330 $aThis book highlights the applications of coupled bioluminescence assay techniques to real-world problems in drug discovery, environmental and chemical analysis, and biodefense. It separates theoretical aspects from the applied sections in a clear and readable way. Coupled Bioluminescent Assays, explains the uses of CB technologies across drug discovery to analyze toxicity, drug receptors, and enzymes. It covers applications in environmental analysis and biodefense, including cytotoxicity, fertilizer and explosives analysis, and nerve agent and pesticide detection. This is the premier reference 606 $aBioluminescence assay 615 0$aBioluminescence assay. 676 $a612/.01442 700 $aCorey$b Michael J$g(Michael James),$f1953-$0989967 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910144113903321 996 $aCoupled bioluminescent assays$92264268 997 $aUNINA LEADER 03969nam 2201285z- 450 001 9910576879403321 005 20220621 035 $a(CKB)5720000000008381 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/84510 035 $a(oapen)doab84510 035 $a(EXLCZ)995720000000008381 100 $a20202206d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aAge-Related Macular Degeneration and Diabetic Retinopathy 210 $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022 215 $a1 online resource (228 p.) 311 08$a3-0365-4210-8 311 08$a3-0365-4209-4 330 $aThis reprint includes contributions from leaders in the field of personalized medicine in ophthalmology. The contributions are diverse and cover pre-clinical and clinical topics. We hope you enjoy reading the articles. 606 $aBiology, life sciences$2bicssc 606 $aResearch and information: general$2bicssc 610 $a3D models 610 $a577-nm laser 610 $aage-related macular degeneration 610 $aAMD 610 $aanti-vascular endothelial growth factor 610 $aanti-VEGF 610 $aanti-VEGF therapy 610 $aAT1-receptor 610 $aautoantibodies 610 $aautofluorescence 610 $abiomarker 610 $abiomarkers 610 $ablood-neural barriers 610 $aC4 610 $acentral area thickness 610 $achoroidal neovascularization 610 $aclassification 610 $acomplement system 610 $adiabetic macular edema 610 $adiabetic macular oedema 610 $adiabetic retinopathy 610 $adiabetic retinopathy severity scale 610 $adisease modeling 610 $aedema 610 $aETDRS classification 610 $aethnicity 610 $afactor I 610 $ageneral practice 610 $agenetic variants 610 $aglucose variability 610 $aglycemic gap 610 $aHDL 610 $aindicators 610 $ainner blood-retinal barrier 610 $aintravitreal aflibercept 610 $alaser fixed parameters 610 $aleakage index 610 $amachine learning 610 $amass spectrometry 610 $ametabolites 610 $amicroaneurysms 610 $amicrophysiological systems 610 $amicroRNA 610 $an/a 610 $aneovascular age-related macular degeneration 610 $aneovascularization 610 $aneurovascular unit 610 $aOCT 610 $aoptical coherence tomography 610 $aorgan-on-a-chip 610 $apanretinal leakage index 610 $aPAR1 610 $apersonalized medicine 610 $aphenotypes 610 $aprecision medicine 610 $aprogression 610 $aquantitative biomarkers 610 $areal-life 610 $aretina 610 $aretinal imaging 610 $aretinal thickness 610 $aretinopathy 610 $arisk factors 610 $asemi-quantitative multiplex profilin 610 $asubthreshold micropulse laser 610 $atomography 610 $atype 2 diabetes 610 $aultra-widefield fluorescein angiography 610 $avariability 610 $aVEGF-A 610 $aVEGF-B 610 $aVEGF-receptor 2 610 $avisual acuity 610 $avisual prognosis 610 $avitronectin 615 7$aBiology, life sciences 615 7$aResearch and information: general 700 $aWestenskow$b Peter D$4edt$01293852 702 $aEbneter$b Andreas$4edt 702 $aWestenskow$b Peter D$4oth 702 $aEbneter$b Andreas$4oth 906 $aBOOK 912 $a9910576879403321 996 $aAge-Related Macular Degeneration and Diabetic Retinopathy$93022783 997 $aUNINA